Clinical Trials Unit
The Paramedic 3 Trial has shown the use of intraosseous administration of adrenaline, compared with intravenous administration, in out-of-hospital cardiac arrest did not improve 30-day survival.
The study results will provide key new evidence to inform cardiac arrest clinical guidelines across the world.
The results were presented at the European Resuscitation Council conference in Athens on 31 October 2024
Late Breaking Science: IVIO andPARAMEDIC3 Trials #RESUS24
Paramedic 3 has recently been published in the NEJM, the paper can be found here:
Research excellence
The Warwick Clinical Trials Unit (WCTU) has a strong track record in delivering excellent research. Established in 2005, we received full registration status from the UKCRC in 2007.
We care about patient centred outcomes and we want to find ways to improve them. Our trials and investigations help us to do that. We're not afraid to ask the difficult questions, by leading and supporting clinical trials that seek to find answers. We have a reputation for challenging long-established norms.
Discover Our Work
Our core portfolio trials cover:
- Cancer
- Emergency and critical care
- Methodology
- Maternal Health
- Surgery/Pain and Rehabilitation
Learn more about current, recruiting and follow up trials as well as completed trials in our Trials Portfolio section.
Collaborate with us
We specialise in the development and delivery of large multicentre clinical trials.
Whether you need support for specific services or full trial management, we can help.
Discover more about the services we provide by visiting Collaborate with WCTU.
Our funding
Warwick CTU is part of the NIHR Research Support Service – RSS – a national service providing support and advice to researchers based in England developing funding applications at all stages of the research pathway, from pre award to post award and delivery.
